Skip to content
Screener

Innoviva, Inc. INVA Price / book

Price / book at other companies

Pfizer logo
PfizerPFE
1.8×+0.2×
Merck & Co. logo
Merck & Co.MRK
7.6×+3.5×
AbbVie logo
AbbVieABBV
261×+221×
Insmed logo
InsmedINSM
30.5×+14.4×
Savara logo
SavaraSVRA
6.3×+3.1×
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
3.1×0.0×

Other financials

Income statement

See full
Revenue$119.6M+19.3%
Gross profit$90.6M+9.0%
Operating income$50.9M+4.3%
Net income-$83.4M-231%
EPS (diluted)-$1.14-248%

Balance sheet

See full
Cash & equivalents$570.4M+43.5%
Total debt$269.7M-40.2%
Total equity$1.2B—
Total assets$1.7B+27.7%

Cash flow

See full
Operating cash flow$52.0M+17.9%
CapEx$429.0K—
Free cash flow$51.5M+16.9%

Valuation

See full
Market cap$1.53B+33.1%
Enterprise value$1.22B+2.1%
P/E4.3×-25.4×
P/S3.5×+0.4×

Profitability

See full
Gross margin72.2%-10.9pp
Operating margin36.9%-10.7pp
Net margin81.2%+70.8pp
FCF margin43.1%-11.1pp

Returns & leverage

See full
Return on equity29.1%—
Debt / equity0.2×—
Current ratio16×+13.4×

Where this comes from

Calculated from Innoviva, Inc.’s reported figures.

market cap/total stockholders equity=1.4×

Based on the most recent quarter.

The source filing: Innoviva, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:26 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335235

FAQ

What is Innoviva, Inc.'s price / book?
Innoviva, Inc. (INVA) reported price / book of 1.4× in Q2 2026.
What is the long-term trend for Innoviva, Inc.'s price / book?
Over 4 years (2020 to 2025), Innoviva, Inc.'s price / book has grown at a -5.5% compound annual growth rate (CAGR), from 1.6× to 1.3×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Innoviva, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude